Home / IBT-B.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does IBT-B.ST make money? Does IBT-B.ST have pricing power? What's the Earnings Whisper? Will IBT-B.ST profit more as the business scales? What is IBT-B.ST's management track record? Is IBT-B.ST's current price justified?

Infant Bacterial Therapeutics AB (publ)

SEK 65.70 +$15.90 (+31.93%)

STO · 30 Oct 2026 11:45 UTC

Previous Close

SEK 68.30

Day Range

SEK 65.10SEK 68.20

Year Range

SEK 43.25SEK 84.90

Market Cap

885.07M

AVG Volume

7.68K

Trailing/Forward PE

-10.79/2.67

PEG ratio

1.43

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · Q

IBT-B.ST Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	-1K
24 Q3	0
24 Q2	0
24 Q1	5K

Net Income (SEK) · Q

IBT-B.ST Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q2	-29.73M
26 Q1	-22.93M
25 Q4	-19.2M
25 Q3	-10.05M
25 Q2	-19.17M
25 Q1	-16.74M
24 Q4	-33.77M
24 Q3	-32.65M
24 Q2	-42.67M
24 Q1	-27.82M

Operating Income (SEK) · Q

IBT-B.ST Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q2	-30.24M
26 Q1	-23.5M
25 Q4	-20.54M
25 Q3	-10.84M
25 Q2	-20.13M
25 Q1	-17.5M
24 Q4	-37.45M
24 Q3	-33.82M
24 Q2	-44.28M
24 Q1	-29.8M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (SEK) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 13 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Infant Bacterial Therapeutics AB (publ)

Earnings: IBT-B.ST

Video analysis: IBT-B.ST

News: IBT-B.ST

Similar companies